On Sep. 4, 2024, researcher led by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University Medical Center (VUMC) announced that a large multicenter study found that adults 60 and older who received an RSV vaccine were significantly less likely to be hospitalized with RSV than those who were not vaccinated.

The study conducted in 19 states between October 2023 and March 2024 demonstrated that RSV vaccination was 75% effective in preventing RSV-associated hospitalizations for adults age 60 and older. The study results were published in the Journal of the American Medical Association (JAMA).